JoVE Logo

Anmelden

6.18 : Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal of Schlemm are located at the iridocorneal angle, where the iris and cornea meet.

In glaucoma, the iridocorneal angle becomes blocked, causing an imbalance between aqueous humor secretion and drainage. When the trabecular meshwork becomes stiff, the outflow of aqueous humor slows down. Consequently, the aqueous humor gradually accumulates in the anterior chamber, increasing intraocular pressure. This condition is referred to as open-angle glaucoma because the iridocorneal angle remains open. Angle-closure glaucoma occurs when the iris bulges and obstructs the iridocorneal angle, leading to a sudden rise in intraocular pressure. Both types of glaucoma can be managed with medications or surgical interventions.

Tags

GlaucomaIntraocular PressureRetinaOptic NerveBlindnessAqueous HumorCiliary BodyTrabecular MeshworkCanal Of SchlemmIridocorneal AngleOpen angle GlaucomaAngle closure GlaucomaMedicationsSurgical Interventions

Aus Kapitel 6:

article

Now Playing

6.18 : Glaucoma: Overview

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

482 Ansichten

article

6.1 : Adrenerge Neuronen: Neurotransmission

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

3.3K Ansichten

article

6.2 : Adrenerge Rezeptoren (Adrenozeptoren): Klassifikation

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

2.1K Ansichten

article

6.3 : Adrenerge Rezeptoren: ɑ Subtyp

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.3K Ansichten

article

6.4 : Adrenerge Rezeptoren: β Subtyp

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.4K Ansichten

article

6.5 : Adrenerge Agonisten: Direkt wirkende Wirkstoffe

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.3K Ansichten

article

6.6 : Adrenerge Agonisten: indirekt wirkende Agenzien

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.4K Ansichten

article

6.7 : Adrenerge Agonisten: Mixed-Action-Wirkstoffe

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

632 Ansichten

article

6.8 : Adrenerge Agonisten: Chemie und Struktur-Wirkungs-Beziehung

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

2.5K Ansichten

article

6.9 : Adrenerge Agonisten: Therapeutische Klassifikation

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

653 Ansichten

article

6.10 : Adrenerge Agonisten: Therapeutische Anwendungen

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

693 Ansichten

article

6.11 : Adrenerge Antagonisten: Chemie und Klassifikation von ɑ-Rezeptorblockern

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

769 Ansichten

article

6.12 : Adrenerge Antagonisten: Pharmakologische Wirkungen von ɑ-Rezeptor-Blockern

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

514 Ansichten

article

6.13 : Adrenerge Antagonisten: Chemie und Klassifikation von β-Rezeptor-Blockern

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

475 Ansichten

article

6.14 : Adrenerge Antagonisten: Pharmakologische Wirkungen von β-Rezeptor-Blockern

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

504 Ansichten

See More

JoVE Logo

Datenschutz

Nutzungsbedingungen

Richtlinien

Forschung

Lehre

ÜBER JoVE

Copyright © 2025 MyJoVE Corporation. Alle Rechte vorbehalten